Cargando…
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma
Patients with extrahepatic cholangiocarcinoma (EHCC) have a poor prognosis; postoperative survival depends on cancer progression and therapeutic resistance. The mechanism of EHCC progression needs to be clarified to identify ways to improve disease prognosis. Stathmin1 (STMN1) is a major cytosolic p...
Autores principales: | Watanabe, Akira, Suzuki, Hideki, Yokobori, Takehiko, Tsukagoshi, Mariko, Altan, Bolag, Kubo, Norio, Suzuki, Shigemasa, Araki, Kenichiro, Wada, Satoshi, Kashiwabara, Kenji, Hosouchi, Yasuo, Kuwano, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317896/ https://www.ncbi.nlm.nih.gov/pubmed/24708177 http://dx.doi.org/10.1111/cas.12417 |
Ejemplares similares
-
Overexpression of natural killer group 2 member D ligands predicts favorable prognosis in cholangiocarcinoma
por: Tsukagoshi, Mariko, et al.
Publicado: (2016) -
Poor prognosis in cholangiocarcinoma patients with low FBXW7 expression is improved by chemotherapy
por: Ishii, Norihiro, et al.
Publicado: (2017) -
Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins
por: Tsukagoshi, Mariko, et al.
Publicado: (2017) -
Reduced FBXW7 expression in pancreatic cancer correlates with poor prognosis and chemotherapeutic resistance via accumulation of MCL1
por: Ishii, Norihiro, et al.
Publicado: (2017) -
Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppression
por: Igarashi, Takamichi, et al.
Publicado: (2017)